Here, we found that IL-17A treatment promoted the proliferation of Ph+ B-ALL cells by activating the IL6/JAK/STAT3 signalling pathway, which is consistent with the previous study. The gene discussed is IL6; the disease is acute lymphoblastic leukemia.